Breast cancer : Six years evaluation

Christian Sumilat1 , Daniel Sampepajung2,

Surgical Resident1 , Professor of Surgical Oncology Department2,
Faculty of Medicine Hasanuddin University, Makassar

Introduction: Breast cancer is malignancy in the breast tissue originating from the ductal epithelium and lobules. Breast cancer is one of the most common
types of cancer in Indonesia.

Objective: This study aims to evaluate cases of breast cancer in Ibnu Sina Hospital, Makassar for 6 years based on age, history of parity, tumor location,
clinically stage, choice of therapy, type of histopathology, differentiation degree, and immunohistochemistry subtypes.

Method:
•Retrospective descriptive study by using secondary data from patient’s medical record at Ibnu Sina Hospital, Makassar.
•Total population sampling : 627 patients from Januari 2012 to December 2017
Result:

Result
•The highest age group frequency is the group of 41-50 years old and the lowest group age is the
group of 71-80 years old.
•The frequency of multiparaous group was higher than nulliparaous group.
•The most common location was left breast.
•The highest number of breast cancer by stage was stage III.
•The most common treatment modality was surgical therapy (both lumpectomy and mastectomy).
•The most common histopathology type was invasive ductal carcinoma.
•The most common degree of differentiation was moderate differentiation.
•Immunohistochemistry subtypes were obtained with the highest percentage of luminal B and the
lowest triple negative results were 31 cases (4.94%).

The survival rate of less than 5

years of breast cancer patients in
this study, 315 cases (50.2%),
while the survival rate of more
than 5 years was 78 cases (12.4%).

About 37.4% of the patients didn’t

return for follow up.

Conclusion: Recommendation:
• The incidence of cancer sufferers tends to increase throughout the world so that it will become a problem
•The percentage of breast cancer patients
that needs attention from the government. Therefore, early detection is one of the best primary
with survival rate less than 5 years was prevention at this time.
higher than that of survival rate more
than 5 years because the majority of • Applying a healthy lifestyle, avoiding risk factors, and routinely carrying out breast self-examination (BSE)
is an alternative prevention of disease.
breast cancer patients came to seek
medical treatment in late stages. • Cancer screening is one of the most important in reducing mortality in patients with breast cancer.
•Some patients didn’t return for follow- • It requires harder work from medical practitioners in educating patients so that the patients understand
up, so that they could not be evaluated all the risks associated with the disease and follow advice from oncology surgeons regarding optimal
whether these patients were die or alive. treatment.

REFERENCES
1. Ghoncheh M, Zahra P, dan Hamid S. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev, vol 17,
cancer control in Western Asia Special Issue, 2016\
2. Ayu G, Dewi T, Hendrati LY, Ua FKM, Epidemiologi D, Ua FKM. Analisis risiko kanker payudara berdasar riwayat pemakaian kontrasepsi hormonal
dan usia. 2013;12–23.
3. Humaera R, dan Syazili M. Diagnosis dan Penatalaksanaan Karsinoma Mammae Stadium 2. J Medula Unila, vol 7, no 2, (2017); 103-107
4. Priyatin C, faktor risiko yang berpengaruh terhadap kejadian kanker payudara di RSUP DR. Kariadi semarang. jurnal kebidanan no 2 volume 5. 2013
5. Azril Ardiansyah, AO. Surgery Mapping Oncology series: Breast Cancer. Malang: Airlangga University Press & LPS UNAIR. pp1-5
6. William Hoffman BL, et al. Breast Disease in Williams Gynecology 3rd ed. New York: McGraw-Hill. pp 275-292: 2016
7. Dewi GAT, dan Lucia YH. Analisis Risiko Kanker Payudara berdasarkan Riwayat Pemakaian Kontrasepsi Hormonal dan Usia Menarche. Jurnal
Berkala Epidemiologi, vol 3, no 1, (2015): 12-23
8. Mohammad FA, et al. Efficacy Instructional Training Program in Breast Self-Examination & Breast Screening for Cancer among University Student.
Public Health research, 2013, 3(3): 71-78
9. Wang L. Early Diagnosis of Breast Cancer. Sensors, 2017, 17, 1572
10. Ramli, M. Update Breast Cancer Management Diagnostic and Treatment. Majalaj Kedokteran Andalas, vol 38, no suppl 1, (2015)
11. Gaol HL, dan Farida B. Kanker Payudara dalam Kapita Selekta Kedokteran jilid 1. Ed 4. Jakarta: Media Aesculapius. 2014, pp 230-236
12. Kumiko S, dan Tomotaka S. Epidemiology of Breast Cancer in Japan and the US. JMAJ, 52(1): 39-44, 2009
13. Ostad SN, dan MAliheh P. Breast Cancer from Molecular Point of View: Pathogenesis and Biomarkers: chapter 6 In Breast Cancer- Focusing Tumor
Microenvironment, Stem Cell and Metastasis. China: Intech. 2011, pp 103-127
14. Angahar LT. An Overview of Breast Cancer Epidemiology, Risk Factors, Pthophysiology, and Cancer Risks Reduction. MOJ Biol Med, 2017, 1(4):
00019
15. Coughlin SS dan Yasmin C. Epidemiology of Breast Cancer in Women. New York: Springer Science. 2013
16. McGuire A, et al. Effects of Age on the Detection and Management of Breast Cancer. Cancers, 2015, 7, pp 908-929
17. Shah R, et al. Pathogenesus, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol, 2014, 10;5(£): 283-298
18. Kabel AM, dan Fahad HB. Breast Cancer: Insights into Risk Factors, Pathogenesis, Diagnosis and Management. Journal of cancer Research and Treatment, (2015), vol 3, no 2:
28-33
19. Mohan. Harsh. Textbook of pathology sixth edition. Jaypee Brothers Medical Publishers. 2010
20. American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta: American Cancer Society , Inc. 2017
21. Jiemin Ma dan Ahmedin J. Breast Cancer Statistic. New York: Springer Science. 2013
22. Nounou MI, et al. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer: Basic and Clinical Research, 2015:
9(S2)
23. Gruver AM, et al. Molecular Pathology of Breast Cancer: The Journey from Traditional Practice Toward Embracing the Complexity of a Molecular Classification. Arch Pathol
Lab Med, 2011; 135: 544-557
24. Hartaningsih D, Sudarsa W. Kanker Payudara pada wanita usia muda di bagia bedah onkologi rumah sakit umum pusat sanglah Denpasar tahun 2002-2012. Bali medical journal
2013
25. Wijaya P, Manuaba W. Hubungan subtype imunohistokimia dengan usia pada pasien kanker payudata di RSUP Sanglah Kota Denpasar. e-junal medica, VOL. 6 NO.3, maret, 2017
26. Ohene-Yeboah M, Adjei E. Breast cancer in Kumasi, Ghana. Ghana Med J.2006;46(1):8–13.
27. Bibhusal Thapa, Yogendra Singh, Prakash Sayami, Uttam Krishna Shrest, Ranjan Sapkota, Gita Sayami. Breast Cancer in Young Women from a Low Risk Population in Nepal. Asian Pasific Journal of
Cancer Prevention. 2013;14 : 5095 - 5099
28. Balekouzou A, Yin P, Pamatika CM, Bishwajit G, Nambei SW, Djeintote M, et al. Epidemiology of breast cancer : retrospective study in the Central African Republic. BMC
Public Health [Internet]. 2016;1–10. Available from: http://dx.doi.org/10.1186/s12889-016-3863-6
29. Liana LK, Ii KP, Yuniawati E. Angka Kejadian Karsinoma Mammae di Rumah Sakit Immanuel Bandung Periode Januari 2007 – Desember 2009 Prevalence of Breast Cancer in
Immanuel Hospital Bandung through January 2007 to Desember 2009. 2010;
30. Rummel S, Hueman MT, Costantino N, Shriver CD, Ellsworth RE. Tumour location within the breast : Does tumour site have prognostic ability ? :1–10.